The Aerosol Drug Management Improvement Team

Slides:



Advertisements
Similar presentations
RESPIRATORY EMERGENCIES. Nose/mouth – pharynx/oropharynx – Larynx – Trachea – Bronchi – Bronchioles – Lungs- Alveoli.
Advertisements

Inhalers The Perfect technique Vicky Walker Clinical Lead for Respiratory Services Sarah Wilson Respiratory Nurse Specialist.
Asthma Medication Administration Marcia Winston, MSN,CPNP,AE-C The Children’s Hospital of Philadelphia Division of Pulmonary Medicine.
Steps to better asthma care A guide for primary care.
Practical Nursing Diploma Program - Semester 2 Lab Oxygen therapy, Incentive Spirometry, Pulse Oximetry &Sputum Collection.
Rescue Inhaler: Helping Students with Asthma Breathe Better Rachel Gallagher, R.N., A.P.N.P. The Department of Public Instruction School Nurse Consultant.
Nebulized Medication Administration Rachel Gallagher, RN, CPNP, NCSN DPI School Nursing Consultant (608)
NUR 232: SKILL 21-6 Using Metered-Dose Inhalers
Respiratory Prescribing in Tower Hamlets Bill Sandhu Head of Medicines Management, Tower Hamlets Medicines Management Team.
The Least Imperfect Device Karen Meade Clinical Nurse Specialist The Hillingdon Hospital.
Respiratory Measurement and Treatment Gail M. Maier, Ph.D., R.N. Associate Director, ED&R The Ohio State University Wexner Medical Center Peak Flow and.
Inappropriate use of inhalers Inhalation step by step: What your patients SHOULD be doing Step 1: Remove the cap from the inhaler. Step 2: Shake the.
Managing asthma & Inhaler devices for respiratory disease.
Inhaler technique is it important?. Compton et al (2006) Review of evidence from 6 European countries ( Spain, Italy, France, Germany, Netherlands, UK)
Improving Medication Adherence in COPD with an Effective Device Orapan Poachanukoon, MD.
Perform and therapeutic benefit of Using a Nebuliser / Inhaler correctly Devangna Bhatia.
Paediatric Asthma Maria Tracey Paediatric Pharmacist Jane Davis Paediatric Clinical Nurse Specialist CF/Respiratory Royal Alexandra Hospital Paisley.
MANAGEMENT OF ASTHMA 6 Penaflor, Dominic Quinto, Milraam Ramos,Josefa Victoria Sicat, Gracie Suaco, David Tio- Cuizon, Jeremiah Valenzuela, Virginia Lou.
MEDICAL DEVICES Asthma Control:. Hi there, remember me? I’m Julie, your asthma trainer. Do you remember earlier in our conversation I mentioned I use.
Asthma Caring for children with asthma in a community program
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 3 Administration of Aerosolized Agents.
1 Asthma October 30, Weiss, Gergen, & Hodgson (1992)2 Pediatric Statistics Prevalence increasing School absences Estimated as more than 10 million.
David P. Arpino, RRT, RPFT ALHE 4060 – Research in Allied Health Dr. Masini August 2, 2007.
Inhalation Devices Heba Abd El-fattah Sabry Pharm D.
Asthma Medication and Devices Update Lisa C. Johnson RRT, RCP, BAS, AE-C Pediatric Asthma Program Vidant Medical Center.
1 Asthma. 2 Disease of the airways that carry air in and out of the lungs Asthma causes: –Airways to narrow –Lining to swell –Cells to produce more mucus.
MEDICAL DEVICES Asthma Control:. Learning to Monitor and Control Your Asthma Hi there, remember me? I’m Julie, your asthma trainer. Do you remember earlier.
Advances in Pediatric Asthma Care Keyvan Rafei, MD, MBA Division Head, Pediatric Emergency Medicine Chairman, Pediatric Asthma Program.
Quick Fixes for Poor Asthma Control Barbara Carroll Langham RN,BSN Pediatric Asthma Care Manager Kaiser Permanente.
Taper DPI FeatureImpact Efficacy Safety Compliance Cost High Efficiency  Equivalent lung dose achieved in- vitro with approximately 50% lower delivered.
Asthma and COPD Some highlights. How the lungs work 2.
Wheeze and Asthma Key Facts and Updates Dr Reena Bhatt, Paediatric Darzi Fellow in Asthma.
Asthma and Small Airway Inflammation
For Employees of the Randolph County School System
Use of Inhalers and Nebulizers Staff Training
Lung function in health and disease
Effect of gas density on aerosol delivery from a pressurized metered-dose inhaler (pMDI) and jet nebulizer. A. Albuterol was administered via a pMDI and.
John Haughney, David Price, Neil C. Barnes, J
Devices, demonstration and discussion
Linda Cherry Community Respiratory Practitioner.
Monitoring asthma in primary care
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD
Improving Inhaler Technique
Aerosol Therapy & HFNC Natalie Napolitano, MPH, RRT-NPS, FAARC
COPD Management.
Respiratory Disorders
Unlocking the Secrets to Maximize Pulmonary Medications
Chapter 3 Administration of Aerosolized Agents
Mild to Moderate Asthma
Therapeutic Strategies in COPD Focus on Patient Characteristics and Drug Delivery.
A Primer on Medication Delivery Systems in COPD Management
A Primer on Medication Delivery Systems in COPD Management
The Aerosol Drug Management Improvement Team
INHALATION THERAPY FOR ASTHMA AND COPD
CFCs in inhalers for asthma and COPD
AEROSOL THERAPY.
INHALATION THERAPY FOR ASTHMA AND COPD
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: A real-world observational study  David Price, FRCGP,
The 4th Family Medicine Review Course
Chaney et al.’s funhaler study (2004)
The Aerosol Drug Management Improvement Team
The Aerosol Drug Management Improvement Team
PEP-whistle or PEP-mask
The Aerosol Drug Management Improvement Team
The Aerosol Drug Management Improvement Team
The Aerosol Drug Management Improvement Team
The Aerosol Drug Management Improvement Team
The Aerosol Drug Management Improvement Team
Presentation transcript:

The Aerosol Drug Management Improvement Team ADMIT Slide Deck 2018

Part 4 Inhalers for children – Choosing and Using Sören Pedersen

Inhaler choice in children: considerations Ease of use Simple inhalation technique Convenience Drugs available in the inhaler Price In-vitro characteristics No single inhaler satisfies the needs of all age groups

It may be better for a clinician to focus Inhaler choice in children >100 different inhaler/drug combinations are available. This increases the likelihood of finding an appropriate inhaler. It also increases complexity and health-providers’ experience with each individual inhaler. It may be better for a clinician to focus on a limited number of inhalers to get better experience with the devices used Most frequently used devices: Pressurized metered dose inhalers (pMDI) Spacer devices Nebulizers Dry powder inhalers (DPI)

Inhalation therapy: retail sales of inhalation devices in Europe DPIs are the most commonly used in Europe, but marked differences are seen between countries Worldwide pMDIs are the most commonly used Lavorini et al Respir Med 2011;105(7)1099-1103)

Inhaler choice in children Pedersen S, Allergy 1986;41:118-124

children on regular treatment with a pMDI use it correctly Inhaler choice in children: common problems with pMDIs No shaking No exhalation prior to inspiration Less than 50% of school children on regular treatment with a pMDI use it correctly Co-ordination problems Optimal inspiratory flow Bronchoconstriction – cough (lubricants and CFCs) Cold freon effect Inhalation through the nose

No exhalation prior to inspiration Inhaler choice in children: breath-actuated HFA-pMDIs effect on children’s problems with correct inhaler technique No shaking No exhalation prior to inspiration Co-ordination problems Optimal inspiratory flow Bronchoconstriction (lubricants and CFCs) Cold freon effect Inhalation through the nose

No exhalation prior to inspiration Inhaler choice in children: effect of spacers on the most common problems with pMDIs No shaking No exhalation prior to inspiration ? Co-ordination problems Optimal inspiratory flow Bronchoconstriction (lubricants and CFCs) Cold freon effect Inhalation through the nose

Air leakage around mouth-piece Inhaler choice in children: main problems with spacers school-age children Inconvenient Air leakage around mouth-piece Multiple actuations in spacer Delay between actuation and inhalation Shallow, fast inhalations Static electricity (device dependent) Cleaning

Inhaler choice in children: main problems with spacers in pre-school children Air leakage around mouth-piece/face mask Multiple actuations Delay between actuation and inhalation Shallow, fast inhalations Static electricity (device dependent) Spacer volume may be too big for very young children Many young children need a face mask attached to the space. Some masks have a high dead space (rebreathing) if inhalation is shallow Valve may stick and not open correctly

Inhaler choice in children: PIF through Turbohaler in 265 children After 2 corrections After demonstration 120 110 100 90 80 70 60 50 40 30 20 10 3 5 7 9 11 13 15 17 19 PIFR (l/min) Age (years) Pedersen et al, 1996

Inhaler choice in children: inspiratory flow profiles through a DPI Inhaled volume (L) L/min 80 2 2.5 0.5

Inhaler choice in children Time [sec] 0,2 0,6 1,0 Flow [l/min] 60 30 0,4 0,8

Inhaler choice in children Exhalation through the inhaler (device dependent) Insufficient inspiratory flow rate (device dependent) Loading difficulties (device dependent) “Slow-start” inhalation profile (device dependent) Shallow inhalation

Correct inhaler use > 90% of time Inhaler choice in children Age (years) 1 2 3 4 5 6 7 8 9 20 40 60 80 100 % of patients DPI pMDI Spacer Nebulizer QVAR Correct inhaler use > 90% of time Pedersen S et al. Prim Care Respir J. 2010; 19(3):209-16

Inhaler choice in children: likelihood of correct inhaler use after tuition High pMDI-spacer Nebuliser DPI BA-pMDI Medium pMDI Low < 6 years 6 – 12 years

Inhalation therapy: welcome technical developments MDIs Dose counters and adherence monitoring More breath-actuated devices Teaching aids and feed-back systems DPIs Dose counters and adherence monitoring Inhalers in which exhalation through the device prior to inhalation does not affect dosing or particle size Devices which do not release the dose until a sufficient inspiratory flow rate has been reached Teaching and handling aids (latter mainly for elderly and arthritis)

Inhaler choice in children: GINA 2014 children 5 years and younger Inhaler Strategy Age Preferred Device Alternative Device 0–3 years Pressurised metered-dose inhaler plus dedicated spacer with face mask Nebuliser with face mask 4-5 years Pressurised metered-dose inhaler plus dedicated spacer with mouthpiece Pressurised metered-dose inhaler plus dedicated spacer with face mask or nebuliser with mouthpiece or face mask

Outcome – New challenges Assessment of asthma control: problems with symptom based assessment in children Challenges Solutions Outcome – New challenges